Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Q3 2025 value amounting to 0.97%.

  • Ironwood Pharmaceuticals' Return on Capital Employed rose 6800.0% to 0.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97%, marking a year-over-year increase of 6800.0%. This contributed to the annual value of 0.25% for FY2024, which is 21100.0% up from last year.
  • According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Return on Capital Employed is 0.97%, which was up 6800.0% from 0.72% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.97% for Q3 2025, and its period low was 4.91% during Q1 2024.
  • For the 5-year period, Ironwood Pharmaceuticals' Return on Capital Employed averaged around 0.47%, with its median value being 0.25% (2021).
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Return on Capital Employed crashed by -51400bps in 2024, and later soared by 50900bps in 2025.
  • Ironwood Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.25% in 2021, then decreased by -3bps to 0.24% in 2022, then tumbled by -1882bps to 4.27% in 2023, then soared by 107bps to 0.28% in 2024, then skyrocketed by 245bps to 0.97% in 2025.
  • Its last three reported values are 0.97% in Q3 2025, 0.72% for Q2 2025, and 0.18% during Q1 2025.